 |
 |

Neocortical Atrophy, Third Ventricular Width, and Cognitive Dysfunction in Multiple Sclerosis
Ralph H. B. Benedict, PhD;
Jared M. Bruce, PhD;
Michael G. Dwyer, BS;
Nadir Abdelrahman, MD;
Sarah Hussein, BS;
Bianca Weinstock-Guttman, MD;
Neeta Garg, MD;
Frederick Munschauer, MD;
Robert Zivadinov, MD
Arch Neurol. 2006;63:1301-1306.
Background Cognitive dysfunction is common in multiple sclerosis (MS). Correlations are reported between atrophy and neuropsychological test results.
Objective To determine if neocortical volume would supplant or supplement third ventricular width and other magnetic resonance imaging measures when predicting neuropsychological impairment.
Design Cross-sectional study.
Setting University MS clinic.
Participants Seventy-seven patients with relapsing-remitting MS, 42 patients with secondary progressive MS, and 27 healthy control subjects.
Main Outcome Measures Brain atrophy and lesion burden measures were obtained in all patients. A subset of 82 patients and all controls underwent neuropsychological testing.
Results Patients with secondary progressive MS had more atrophy than patients with relapsing-remitting MS and controls. Neocortical volume was significantly correlated with all neuropsychological measures, with r values ranging from 0.29 to 0.58. Third ventricular width was retained in most stepwise regression analyses predicting cognitive impairment in patients with MS and distinguishing secondary progressive from relapsing-remitting courses of MS.
Conclusions We confirm an association between neocortical volume and multiple cognitive domains in MS, although neocortical volume did not explain significantly more variance than other magnetic resonance imaging measures. Of the magnetic resonance imaging variables studied, third ventricular width was retained in most regression models.
Author Affiliations: Department of Neurology, School of Medicine, State University of New York at Buffalo, and Jacobs Neurological Institute (Drs Benedict and Zivadinov) and Buffalo Neuroimaging Analysis Center (Drs Benedict, Bruce, Abdelrahman, Weinstock-Guttman, Garg, Munschauer, and Zivadinov, Mr Dwyer, and Ms Hussein).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study
Horakova et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:407-414.
ABSTRACT
| FULL TEXT
Regional hippocampal atrophy in multiple sclerosis
Sicotte et al.
Brain 2008;131:1134-1141.
ABSTRACT
| FULL TEXT
Cognitive impairment in relapsing--remitting multiple sclerosis can be predicted by imaging performed several years earlier
Summers et al.
Mult Scler 2008;14:197-204.
ABSTRACT
Comparison of Three Different Methods for Measurement of Cervical Cord Atrophy in Multiple Sclerosis
Zivadinov et al.
Am. J. Neuroradiol. 2008;29:319-325.
ABSTRACT
| FULL TEXT
Association of Neocortical Volume Changes With Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis
Amato et al.
Arch Neurol 2007;64:1157-1161.
ABSTRACT
| FULL TEXT
|